New tools for coronary risk assessment: What are their advantages and limitations?

Circulation

Volumn 105, Issue 7, 2002, Pages 886-892

  Pearson, Thomas A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Heart disease; Prevention; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; ANGIOPLASTY; ARTICLE; ATHEROSCLEROSIS; B SCAN; BYPASS SURGERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC IMAGING; ELECTRON BEAM TOMOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MENOPAUSE; POSITRON EMISSION TOMOGRAPHY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; VASCULAR DISEASE;

ADULT; AGED; ARTERIES; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CORONARY DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037133215     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0702.103727     Document Type: Article

References (40)

1. Prediction of coronary heart disease using risk factor categories
2. Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
3. Is the relationship between serum cholesterol and risk of premature death from coronary, heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
4. Primary prevention of coronary heart disease in women through diet and lifestyle
5. Elucidation of the role of plaque instability and rupture in acute coronary events
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
7. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
8. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
9. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
10. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
11. The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
12. Age as a risk factor: You are as old as your arteries
13. 27th Bethesda Conference: Matching intensity of risk factor management with the hazard for coronary disease events
14. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
15. Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction
16. Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results
17. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Medical office assessment: Writing Group I
18. Prevention of coronary heart disease in clinical practice: Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
19. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III
20. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Tests for silent and inducible ischemia: Writing Group II
21. Value of maximal exercise tests in risk assessment of primary coronary heart disease events in healthy men: Five years' experience of the Seattle Heart Watch study
22. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience
23. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease
24. Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow up of 1173 asymptomatic subjects
25. Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease
26. Coronary calcium does not accurately predict near-term future coronary events in high risk adults
27. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography
28. Assessment of subclinical atherosclerosis and cardiovascular risk
29. Magnetic resonance imaging of the coronary arteries: Clinical results from three dimensional evaluation of a respiratory gated technique
30. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis
31. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk
32. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
33. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study
34. Novel inflammatory markers of coronary risk: Theory versus practice
35. Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men
36. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
37. Long-term effects of pravastatin on plasma concentration of C-reactive protein
38. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
39. Homocysteine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association
40. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease